 |
Page History
...
| Owner(s) | Action Item | Due Date | Status |
|---|---|---|---|
| Group Members | Find any disease elements that are not already represented | Ongoing | Ongoing |
| Working Group | Review the new CDE Spreadsheet for the next meeting (ensure it covers the correct definitions and terms are correct) | Jun 26 | Open |
| Mary Cooper | Look in the CDE browser and see if the terms are used by CDISC | Jun 26 | Open |
| Susan Pannoni | Add column for comments/thoughts to new CDE tab(s) to note reasons for not using elements | Jun 26 | Open |
| Liz Ness | Pull up example for when immunological response could be used | Jun 26 | Open |
| Susan Pannoni | Research immunological response - FDA considers this under biologic agents | Jun 26 | Open |
| Anne Tompkins & Liz Ness | Tumor pathologic response - Uncover form and possible value list. Lymphoma SME? | Jun 26 | Open |
| Cathy Rankin | Forward pathologic response to Susan Pannoni | Jun 26 | Open |
| Diane Paul | Send some examples of QOL performance status | Jun 26 | Open |
Working Group Documents
- Round 5 Response-Procedure Results Document - Document - with CDEs (Last Updated June 2526)
- COH1024V03
- COH1059
- COH2004
- COH2077
- COH2331
- COH2649
- CRFWG_roadmap slide
- Solid tumor evaluation form_GOG
...
